|
|
|
¾àó¹æÀÇ Á¤¼®: Drug Class Review & Real World ¼¼Æ®
|
|
|
ÀÌ»óºÀ
¤Ó
¹Ù¸¥ÀÇÇבּ¸¼Ò
|
|
|
|
- Á¦ÈÞ¸ô ÁÖ¹® ½Ã °í°´º¸»ó, ÀϺΠÀ̺¥Æ® Âü¿© ¹× ÁõÁ¤Ç° ÁõÁ¤, ÇÏ·ç/´çÀÏ ¹è¼Û¿¡¼ Á¦¿ÜµÇ¹Ç·Î Âü°í ¹Ù¶ø´Ï´Ù.
-
-
-
¡º¾àó¹æÀÇ Á¤¼®: Drug Class Review & Real World ¼¼Æ®¡»´Â ´Ü¼øÈ÷ ¾à¿¡ ´ëÇÑ Á¤º¸¸¸À» Á¦°øÇϱâ À§ÇÑ Ã¥Àº ¾Æ´Õ´Ï´Ù. ¾à¿¡ ´ëÇÑ Æ÷°ýÀû ÀÌÇØ¿¡¼ ÇÑ¹ß ´õ ³ª¾Æ°¡ °¡À̵å¶óÀÎÀ̳ª ±Ù°Å ±â¹ÝÀ¸·Î ¾àÀ» ó¹æÇÏ´Â ½ÇÀüÁöħÀ» Á¦½ÃÇÏ´Â °ÍÀÌ ÀÌ Ã¥ÀÇ ±Ã±ØÀûÀÎ ÁöÇâÁ¡ÀÔ´Ï´Ù. ÀÌ°ÍÀÌ ¹Ù·Î "Real world prescription"À̶ó´Â ºÎÁ¦¿¡ ´ã±ä ÀǹÌÀÔ´Ï´Ù.
-
-
Vol. 1
PART 1. ¿©·¯ °èÅë¿¡ µÎ·ç »ç¿ëµÇ´Â ¾à¹° Chapter 01. ÀÚÀ²½Å°æ°è¿¡ ÀÛ¿ëÇÏ´Â ¾à¹° Topic 1. ÀÚÀ²½Å°æ°è -------- -------- 4 Topic 2. Äݸ° ¾à¹° -------- -------- 11 2-1. Äݸ° ÀÛ¿ëÁ¦ -------- 11 2-2. Äݸ° ±æÇ×Á¦ -------- 16 Topic 3. ¾Æµå·¹³¯¸° ¾à¹° -------- 21 3-1. ¾Æµå·¹³¯¸° ÀÛ¿ëÁ¦ -------- 21 3-2. ¾Æµå·¹³¯¸° ±æÇ×Á¦ -------- 30
Chapter 02. Ç׿°ÁõÁ¦/¿ÀŸÄÚÀ̵å·ù [SPECIAL REVIEW] Ç׿°ÁõÁ¦/¿ÀŸÄÚÀ̵å: °³¿ä -------- 38 Topic 4. NSAIDs -------- 42 Topic 5. Leukotriene Á¶ÀýÁ¦ -------- 49 Topic 6. ½ºÅ×·ÎÀ̵å -------- 53
Chapter 03. È÷½ºÅ¸¹Î/¼¼·ÎÅä´Ñ/Prostagladin Topic 7. È÷½ºÅ¸¹Î/Ç×È÷½ºÅ¸¹ÎÁ¦ -------- 60 Topic 8. ¼¼·ÎÅä´Ñ -------- 71 Topic 9. Prostagladin -------- 77
Chapter 04. ÁøÅëÁ¦/ÅëÁõÄ¡·á Topic 10. Non-opioid -------- 85 Topic 11. Opioid -------- 88 Topic 12. ¾Ï¼º ÅëÁõÀÇ ¾à¹°¿ä¹ý -------- 97 Topic 13. ½Å°æº´¼º ÅëÁõÀÇ ¾à¹°¿ä¹ý -------- 109
Chapter 05. Ç×»ýÁ¦/Ç×¾ÏÁ¦/¸é¿ª¾ïÁ¦Á¦ Topic 14. Ç×»ýÁ¦ -------- 124 Topic 15. Ç×¾ÏÁ¦ -------- 140 15-1. ¼¼Æ÷µ¶¼ºÇ×¾ÏÁ¦/¹é±Ý ------...-- 142 15-2. Ç×´ë»çÁ¦ -------- 144 15-3. Ç×¾Ï Ç×»ý¾à -------- 154 15-4. Plant alkaloid -------- 156 15-5. Ç¥ÀûÇ×¾ÏÁ¦ -------- 161 15-6. ¸é¿ªÇ×¾ÏÁ¦ -------- 164 Topic 16. ¸é¿ª¾ïÁ¦Á¦/¸é¿ªÁ¶ÀýÁ¦ -------- 167
PART 2. ½ÉÇ÷°ü/½ÅÀå Chapter 01. [Drug Class Review] ½ÉÇ÷°ü/½ÅÀå¿¡ ÁÖ·Î »ç¿ëµÇ´Â ¾à¹° Topic 1. ÀÌ´¢Á¦(Diuretics) -------- 176 Topic 2. º£Å¸Â÷´ÜÁ¦(Beta blocker) -------- 195 Topic 3. Ä®½·Â÷´ÜÁ¦(Calcium channel blockers, calcium antagonists) -------- 208 Topic 4. ACEI & ARB -------- 221 Topic 5. Ç×Ç÷ÀüÁ¦(Ç×Ç÷¼ÒÆÇÁ¦, Ç×ÀÀ°íÁ¦, Ç÷Àü¿ëÇØÁ¦) -------- 236 5-1. Ç×Ç÷¼ÒÆÇÁ¦(Antiplatelet agents) -------- 236 5-2. Ç×ÀÀ°íÁ¦(Anticoagulants) -------- 249 5-3. Ç÷Àü¿ëÇØÁ¦(Thrombolytics) -------- 262 Topic 6. Ç÷°üÈ®ÀåÁ¦ -------- 264
Chapter 02. Áõ»ó/Áúȯº° ¾àó¹æÀÇ Á¤¼® Topic 10. °íÇ÷¾Ð(Hypertension) -------- 274 Topic 11. ºÎÁ¤¸Æ -------- 287 11-1. Ç׺ÎÁ¤¸ÆÁ¦ -------- 287 11-2. ºÎÁ¤¸ÆÀÇ ¾à¹°¿ä¹ý: Overview -------- 301 Topic 12. ½ÉºÎÀü -------- 302 [SPECIAL REVIEW] ARNI (Angiotensin Receptor Neprilysin Inhibitor) -------- 340 Topic 13. ÇãÇ÷¼º ½ÉÁúȯ -------- 348 [SUPPLEMENT] ÇãÇ÷¼º ½ÉÁúȯ ¿ä¾à -------- 351
PART 3. Ç÷¾× Chapter 01. [Drug Class Review] Ç÷¾×°è¿¡ ÁÖ·Î »ç¿ëµÇ´Â ¾à¹° Topic 1. Ç÷¾×Á¦Á¦ -------- 384 Topic 2. ÁöÇ÷Á¦Á¦ -------- 389 Topic 3. Á¶Ç÷¼ºÀåÀÎÀÚ -------- 397
Chapter 02. Áõ»ó/Áúȯº° ¾àó¹æÀÇ Á¤¼® Topic 4. ö°áÇ̺óÇ÷ -------- 406 Topic 5. °Å´ëÀûÇ÷¸ð±¸ºóÇ÷ -------- 418 Topic 6. ¸é¿ªÇ÷¼ÒÆÇ°¨¼ÒÁõ -------- 424
PART 4. È£Èí±â/¾Ë·¹¸£±â Chapter 01. [Drug Class Review] È£Èí±â/¾Ë·¹¸£±â¿¡ ÁÖ·Î »ç¿ëµÇ´Â ¾à¹° Topic 1. ÁøÇØ°Å´ãÁ¦ -------- 436 1-1. ÁøÇØÁ¦ -------- 436 1-2. °Å´ãÁ¦ -------- 442 Topic 2. ±â°üÁöÈ®ÀåÁ¦ -------- 453 Topic 3. ±¹¼Ò ½ºÅ×·ÎÀ̵å: ÈíÀÔ ½ºÅ×·ÎÀ̵å -------- 462
Chapter 02. Áõ»ó/Áúȯº° ¾àó¹æÀÇ Á¤¼® Topic 4. ¸¸¼º ±âħ -------- 468 [SUPPLEMENT] ¸¸¼º ±âħ: ÁÖ¿ä ¿øÀÎ Áúȯº° Ä¡·á -------- 475 Topic 5. ¸¸¼ºÆó¼â¼º ÆóÁúȯ(COPD) -------- 484 [SUPPLEMENT] GOLD °¡À̵å¶óÀÎÀÇ º¯È -------- 496 [SUPPLEMENT] ¸¸¼ºÆó¼â¼º ÆóÁúȯ(COPD): ±Þ¼º¾ÇÈ -------- 503 [SUPPLEMENT] Phosphodiesterase4 (PDE4) ¾ïÁ¦Á¦ -------- 514 Topic 6. õ½Ä(Asthma) -------- 516 Topic 7. ¾Ë·¹¸£±â ºñ¿°(Allergic rhinitis) -------- 529
PART 5. ¼Òȱâ Chapter 01. [Drug Class Review] ¼Òȱ⿡ ÁÖ·Î »ç¿ëµÇ´Â ¾à¹° Topic 1. À§½Äµµ¿ª·ùÁúȯ/¼Òȼº ±Ë¾ç Ä¡·áÁ¦ -------- 552 1-1. ¾ç¼ºÀÚ ÆßÇÁ ¾ïÁ¦Á¦(Proton pump inhibitor, PPI) -------- 558 1-2. À§»êºÐºñ¾ïÁ¦Á¦: Potassium-Competitive Acid Blockers(PCAB) -------- 572 1-3. À§»êºÐºñ¾ïÁ¦Á¦: Histamine-2 receptor antagonist(H2RA) -------- 577 1-4. Á¦»êÁ¦ -------- 585 1-5. Á¡¸·º¸È£Á¦(Coating agents)/±âŸ ¹æ¾îÀÎÀÚ Áõ°¾àÁ¦ -------- 591 Topic 2. À§Àå°ü¿îµ¿ÃËÁøÁ¦(Prokinetics) -------- 599 Topic 3. Ç×±¸ÅäÁ¦(Anti-emetics) -------- 610 Topic 4. Áö»çÁ¦(Anti-diarrheal agents) -------- 623 Topic 5. º¯ºñ, ¿ÏÇÏÁ¦ -------- 629
Chapter 02. Áõ»ó/Áúȯº° ¾àó¹æÀÇ Á¤¼® Topic 6. ½Ä¿åºÎÁø/½Ä¿åÃËÁøÁ¦(appetite stimulants) -------- 644 Topic 7. ¸¸¼º º¯ºñ -------- 647 Topic 8. À§½Äµµ¿ª·ùÁúȯ -------- 650 Topic 9. ¼Òȼº ±Ë¾ç/Ç︮ÄÚ¹ÚÅÍ °¨¿° -------- 664 [SUPPLEMENT] ¼Òȼº ±Ë¾ç: NSAIDs ¿¬°ü ±Ë¾ç -------- 668 Topic 10. ±â´É¼º À§ÀåÀå¾Ö -------- 683 10-1. ±â´É¼º ¼ÒȺҷ®Áõ -------- 683 10-2. °ú¹Î´ëÀåÁõÈıº -------- 692 Topic 11. ¿°Áõ¼º ÀåÁúȯ -------- 706 [SPECIAL REVIEW] ±Ë¾ç¼º ´ëÀå¿° vs. Å©·Ðº´ -------- 709 Topic 12. ¸¸¼º BÇü °£¿° -------- 725 Topic 13. ¸¸¼º CÇü °£¿° -------- 734 [SPECIAL REVIEW] Pan-genotypic DAA regimens -------- 745
Vol. 2
PART 6. ³»ºÐºñ Chapter 01. [Drug Class Review] ³»ºÐºñ¿¡ ÁÖ·Î »ç¿ëµÇ´Â ¾à¹° Topic 1. ºÎ½Å°ÑÁú È£¸£¸ó/±æÇ×Á¦ -------- 4 Topic 2. »ý½Ä»ù È£¸£¸ó/±æÇ×Á¦ -------- 6 2-1. »ý½Ä»ù È£¸£¸ó -------- 6 2-2. »ý½Ä»ù È£¸£¸ó ±æÇ×Á¦ -------- 18
Chapter 02. Áõ»ó/Áúȯº° ¾àó¹æÀÇ Á¤¼® Topic 3. °©»ó»ù Áúȯ -------- 32 3-1. °©»ó»ù ±â´ÉÀúÇÏÁõ -------- 32 [Âü°í] °©»ó»ù ÁúȯÀ» ÀÌÇØÇϱâ À§ÇÑ ±âÃÊ -------- 32 3-2. °©»ó»ù ±â´ÉÇ×ÁøÁõ -------- 42 Topic 4. ´ç´¢º´ -------- 52 4-1. ´ç´¢º´: Ä¡·á ¹× ¾à¹°¿ä¹ý Overview -------- 52 4-2. ´ç´¢º´: ¾à¹°¿ä¹ý-°æ±¸Ç÷´ç°ÇÏÁ¦ -------- 78 [SUPPLEMENT] Incretin °ü·Ã ¾à¹° -------- 87 4-3. ´ç´¢º´: ¾à¹°¿ä¹ý-ÁÖ»çÁ¦ -------- 96 Topic 5. ÀÌ»óÁöÁúÇ÷Áõ -------- 103 [SPECIAL REVIEW] PCSK9 (Proprotein convertase subtilisin-kexin type 9) ¾ïÁ¦Á¦ -------- 120 Topic 6. ºñ¸¸ -------- 121 [SPECIAL REVIEW] GLP-1 agonist: Liraglutide (Saxenda) -------- 130 Topic 7. °ñ´Ù°øÁõ -------- 142 [SPECIAL REVIEW] °ñ´Ù°øÁõ: ¾à¹°¿ä¹ý: Denosumab (RANKL ´ÜÀÏŬ·ÐÇ×ü) -------- 161 Topic 8. Æó°æ(¿©¼º°»³â±â ÁõÈıº) -------- 178 Topic 9. ³²¼º°»³â±â ÁõÈıº -------- 185
PART 7. ¿ä·Î»ý½Ä±â Chapter 01. [Drug Class Review] ¿ä·Î»ý½Ä±â¿¡ ÁÖ·Î »ç¿ëµÇ´Â ¾à¹° Topic 1. ÇϺοä·ÎÁõ»ó/¹è´¢Àå¾Ö¿¡ »ç¿ëµÇ´Â ¾à¹° -------- 197
Chapter 02. Áõ»ó/Áúȯº° ¾àó¹æÀÇ Á¤¼® Topic 2. ÇϺοä·ÎÁõ»ó/¹è´¢Àå¾Ö -------- 198 2-1. Àü¸³¼±ºñ´ëÁõ -------- 198 2-2. °ú¹Î¼º ¹æ±¤ -------- 215 [SPECIAL REVIEW] °ú¹Î¼º¹æ±¤: ¾à¹°¿ä¹ý: º£Å¸3 ¾Æµå·¹³¯¸° ¼ö¿ëü ÀÛ¿ëÁ¦: mirabegron -------- 220 2-3. ¿ä½Ç±Ý -------- 226 Topic 3. ³²¼º ¼º±â´ÉÀå¾Ö -------- 234 3-1. ¹ß±âºÎÀü -------- 234 3-2. Á¶·çÁõ -------- 246
PART 8. ½Å°æ/Á¤½Å Chapter 01. [Drug Class Review] ½Å°æ/Á¤½Å°è¿¡ ÁÖ·Î »ç¿ëµÇ´Â ¾à¹° Topic 1. GABA ¹× Glutamate¼º ½Å°æÀü´Þ °ü·Ã¾à¹° -------- 256 [Âü°í] GABA/Glutamate -------- 256 1-1. Benzodiazepine -------- 258 1-2. Barbiturate -------- 269 1-3. Ç׳úÀüÁõÁ¦ -------- 275 [SPECIAL REVIEW] Gabapentenoids: gabaVol. 1
PART 1. ¿©·¯ °èÅë¿¡ µÎ·ç »ç¿ëµÇ´Â ¾à¹°
Chapter 01. ÀÚÀ²½Å°æ°è¿¡ ÀÛ¿ëÇÏ´Â ¾à¹°
Topic 1. ÀÚÀ²½Å°æ°è -------- -------- 4
Topic 2. Äݸ° ¾à¹° -------- -------- 11
2-1. Äݸ° ÀÛ¿ëÁ¦ -------- 11
2-2. Äݸ° ±æÇ×Á¦ -------- 16
Topic 3. ¾Æµå·¹³¯¸° ¾à¹° -------- 21
3-1. ¾Æµå·¹³¯¸° ÀÛ¿ëÁ¦ -------- 21
3-2. ¾Æµå·¹³¯¸° ±æÇ×Á¦ -------- 30
Chapter 02. Ç׿°ÁõÁ¦/¿ÀŸÄÚÀ̵å·ù
[SPECIAL REVIEW] Ç׿°ÁõÁ¦/¿ÀŸÄÚÀ̵å: °³¿ä -------- 38
Topic 4. NSAIDs -------- 42
Topic 5. Leukotriene Á¶ÀýÁ¦ -------- 49
Topic 6. ½ºÅ×·ÎÀ̵å -------- 53
Chapter 03. È÷½ºÅ¸¹Î/¼¼·ÎÅä´Ñ/Prostagladin
Topic 7. È÷½ºÅ¸¹Î/Ç×È÷½ºÅ¸¹ÎÁ¦ -------- 60
Topic 8. ¼¼·ÎÅä´Ñ -------- 71
Topic 9. Prostagladin -------- 77
Chapter 04. ÁøÅëÁ¦/ÅëÁõÄ¡·á
Topic 10. Non-opioid -------- 85
Topic 11. Opioid -------- 88
Topic 12. ¾Ï¼º ÅëÁõÀÇ ¾à¹°¿ä¹ý -------- 97
Topic 13. ½Å°æº´¼º ÅëÁõÀÇ ¾à¹°¿ä¹ý -------- 109
Chapter 05. Ç×»ýÁ¦/Ç×¾ÏÁ¦/¸é¿ª¾ïÁ¦Á¦
Topic 14. Ç×»ýÁ¦ -------- 124
Topic 15. Ç×¾ÏÁ¦ -------- 140
15-1. ¼¼Æ÷µ¶¼ºÇ×¾ÏÁ¦/¹é±Ý -------- 142
15-2. Ç×´ë»çÁ¦ -------- 144
15-3. Ç×¾Ï Ç×»ý¾à -------- 154
15-4. Plant alkaloid -------- 156
15-5. Ç¥ÀûÇ×¾ÏÁ¦ -------- 161
15-6. ¸é¿ªÇ×¾ÏÁ¦ -------- 164
Topic 16. ¸é¿ª¾ïÁ¦Á¦/¸é¿ªÁ¶ÀýÁ¦ -------- 167
PART 2. ½ÉÇ÷°ü/½ÅÀå
Chapter 01. [Drug Class Review] ½ÉÇ÷°ü/½ÅÀå¿¡ ÁÖ·Î »ç¿ëµÇ´Â ¾à¹°
Topic 1. ÀÌ´¢Á¦(Diuretics) -------- 176
Topic 2. º£Å¸Â÷´ÜÁ¦(Beta blocker) -------- 195
Topic 3. Ä®½·Â÷´ÜÁ¦(Calcium channel blockers, calcium antagonists) -------- 208
Topic 4. ACEI & ARB -------- 221
Topic 5. Ç×Ç÷ÀüÁ¦(Ç×Ç÷¼ÒÆÇÁ¦, Ç×ÀÀ°íÁ¦, Ç÷Àü¿ëÇØÁ¦) -------- 236
5-1. Ç×Ç÷¼ÒÆÇÁ¦(Antiplatelet agents) -------- 236
5-2. Ç×ÀÀ°íÁ¦(Anticoagulants) -------- 249
5-3. Ç÷Àü¿ëÇØÁ¦(Thrombolytics) -------- 262
Topic 6. Ç÷°üÈ®ÀåÁ¦ -------- 264
Chapter 02. Áõ»ó/Áúȯº° ¾àó¹æÀÇ Á¤¼®
Topic 10. °íÇ÷¾Ð(Hypertension) -------- 274
Topic 11. ºÎÁ¤¸Æ -------- 287
11-1. Ç׺ÎÁ¤¸ÆÁ¦ -------- 287
11-2. ºÎÁ¤¸ÆÀÇ ¾à¹°¿ä¹ý: Overview -------- 301
Topic 12. ½ÉºÎÀü -------- 302
[SPECIAL REVIEW] ARNI (Angiotensin Receptor Neprilysin Inhibitor) -------- 340
Topic 13. ÇãÇ÷¼º ½ÉÁúȯ -------- 348
[SUPPLEMENT] ÇãÇ÷¼º ½ÉÁúȯ ¿ä¾à -------- 351
PART 3. Ç÷¾×
Chapter 01. [Drug Class Review] Ç÷¾×°è¿¡ ÁÖ·Î »ç¿ëµÇ´Â ¾à¹°
Topic 1. Ç÷¾×Á¦Á¦ -------- 384
Topic 2. ÁöÇ÷Á¦Á¦ -------- 389
Topic 3. Á¶Ç÷¼ºÀåÀÎÀÚ -------- 397
Chapter 02. Áõ»ó/Áúȯº° ¾àó¹æÀÇ Á¤¼®
Topic 4. ö°áÇ̺óÇ÷ -------- 406
Topic 5. °Å´ëÀûÇ÷¸ð±¸ºóÇ÷ -------- 418
Topic 6. ¸é¿ªÇ÷¼ÒÆÇ°¨¼ÒÁõ -------- 424
PART 4. È£Èí±â/¾Ë·¹¸£±â
Chapter 01. [Drug Class Review] È£Èí±â/¾Ë·¹¸£±â¿¡ ÁÖ·Î »ç¿ëµÇ´Â ¾à¹°
Topic 1. ÁøÇØ°Å´ãÁ¦ -------- 436
1-1. ÁøÇØÁ¦ -------- 436
1-2. °Å´ãÁ¦ -------- 442
Topic 2. ±â°üÁöÈ®ÀåÁ¦ -------- 453
Topic 3. ±¹¼Ò ½ºÅ×·ÎÀ̵å: ÈíÀÔ ½ºÅ×·ÎÀ̵å -------- 462
Chapter 02. Áõ»ó/Áúȯº° ¾àó¹æÀÇ Á¤¼®
Topic 4. ¸¸¼º ±âħ -------- 468
[SUPPLEMENT] ¸¸¼º ±âħ: ÁÖ¿ä ¿øÀÎ Áúȯº° Ä¡·á -------- 475
Topic 5. ¸¸¼ºÆó¼â¼º ÆóÁúȯ(COPD) -------- 484
[SUPPLEMENT] GOLD °¡À̵å¶óÀÎÀÇ º¯È -------- 496
[SUPPLEMENT] ¸¸¼ºÆó¼â¼º ÆóÁúȯ(COPD): ±Þ¼º¾ÇÈ -------- 503
[SUPPLEMENT] Phosphodiesterase4 (PDE4) ¾ïÁ¦Á¦ -------- 514
Topic 6. õ½Ä(Asthma) -------- 516
Topic 7. ¾Ë·¹¸£±â ºñ¿°(Allergic rhinitis) -------- 529
PART 5. ¼Òȱâ
Chapter 01. [Drug Class Review] ¼Òȱ⿡ ÁÖ·Î »ç¿ëµÇ´Â ¾à¹°
Topic 1. À§½Äµµ¿ª·ùÁúȯ/¼Òȼº ±Ë¾ç Ä¡·áÁ¦ -------- 552
1-1. ¾ç¼ºÀÚ ÆßÇÁ ¾ïÁ¦Á¦(Proton pump inhibitor, PPI) -------- 558
1-2. À§»êºÐºñ¾ïÁ¦Á¦: Potassium-Competitive Acid Blockers(PCAB) -------- 572
1-3. À§»êºÐºñ¾ïÁ¦Á¦: Histamine-2 receptor antagonist(H2RA) -------- 577
1-4. Á¦»êÁ¦ -------- 585
1-5. Á¡¸·º¸È£Á¦(Coating agents)/±âŸ ¹æ¾îÀÎÀÚ Áõ°¾àÁ¦ -------- 591
Topic 2. À§Àå°ü¿îµ¿ÃËÁøÁ¦(Prokinetics) -------- 599
Topic 3. Ç×±¸ÅäÁ¦(Anti-emetics) -------- 610
Topic 4. Áö»çÁ¦(Anti-diarrheal agents) -------- 623
Topic 5. º¯ºñ, ¿ÏÇÏÁ¦ -------- 629
Chapter 02. Áõ»ó/Áúȯº° ¾àó¹æÀÇ Á¤¼®
Topic 6. ½Ä¿åºÎÁø/½Ä¿åÃËÁøÁ¦(appetite stimulants) -------- 644
Topic 7. ¸¸¼º º¯ºñ -------- 647
Topic 8. À§½Äµµ¿ª·ùÁúȯ -------- 650
Topic 9. ¼Òȼº ±Ë¾ç/Ç︮ÄÚ¹ÚÅÍ °¨¿° -------- 664
[SUPPLEMENT] ¼Òȼº ±Ë¾ç: NSAIDs ¿¬°ü ±Ë¾ç -------- 668
Topic 10. ±â´É¼º À§ÀåÀå¾Ö -------- 683
10-1. ±â´É¼º ¼ÒȺҷ®Áõ -------- 683
10-2. °ú¹Î´ëÀåÁõÈıº -------- 692
Topic 11. ¿°Áõ¼º ÀåÁúȯ -------- 706
[SPECIAL REVIEW] ±Ë¾ç¼º ´ëÀå¿° vs. Å©·Ðº´ -------- 709
Topic 12. ¸¸¼º BÇü °£¿° -------- 725
Topic 13. ¸¸¼º CÇü °£¿° -------- 734
[SPECIAL REVIEW] Pan-genotypic DAA regimens -pentin, pregabalin -------- 292 Topic 2. µµÆĹΠ½Å°æÀü´Þ °ü·Ã¾à¹° -------- 297 2-1. Ç×Á¤½Åº´Á¦ -------- 297 Topic 3. Adrenergic, serotonergic ½Å°æÀü´Þ °ü·Ã¾à¹° -------- 315 3-1. Ç׿ì¿ïÁ¦ -------- 315 3-2. ±âºÐÁ¶ÀýÁ¦ -------- 334 Topic 4. ±âŸ -------- 338 4-1. Á¤½ÅÀÚ±ØÁ¦ -------- 338
Chapter 02. Áõ»ó/Áúȯº° ¾àó¹æÀÇ Á¤¼® Topic 5. ÆíµÎÅë -------- 346 Topic 6. ¶³¸²/ÆÄŲ½¼º´ -------- 370 Topic 7. ¹ßÀÛ(seizure)/³úÀüÁõ(epilepsy) -------- 390 Topic 8. ¾îÁö·³Áõ -------- 398 Topic 9. Ä¡¸Å -------- 406 Topic 10. ºÒ¾ÈÀå¾Ö -------- 423 Topic 11. ¿ì¿ïÀå¾Ö -------- 435 Topic 12. ¼ö¸éÀå¾Ö -------- 448 Topic 13. ÁÖÀǷ°áÇÌ°úÀ×ÇൿÀå¾Ö(ADHD) -------- 470 Topic 14. Èí¿¬(±Ý¿¬¾à¹°) -------- 481
PART 9. ´« ±Í ÄÚ µÎ°æºÎ Chapter 01. [Drug Class Review] ´«, ±Í, ÄÚ, µÎ°æºÎ¿¡ ÁÖ·Î »ç¿ëµÇ´Â ¾à¹° Topic 1. ¿Ü¿ëÁ¦(Á¡¾ÈÁ¦) -------- 500 [SUPPLEMENT] ¾È¾àÀÇ ¿Ã¹Ù¸¥ »ç¿ë¹æ¹ý -------- 503 Topic 2. ¿Ü¿ëÁ¦(Á¡ÀÌÁ¦) -------- 506 [SUPPLEMENT] Á¡ÀÌÁ¦ÀÇ ¿Ã¹Ù¸¥ »ç¿ë¹æ¹ý -------- 507
Chapter 02. Áõ»ó/Áúȯº° ¾àó¹æÀÇ Á¤¼® Topic 3. ¿ÜÀ̵µ¿° -------- 510 Topic 4. ¾È±¸°ÇÁ¶Áõ -------- 515 Topic 5. °á¸·¿°: ¾Ë·¹¸£±â°á¸·¿°À» Áß½ÉÀ¸·Î -------- 528 Topic 6. ³ì³»Àå -------- 536
PART 10. ±Ù°ñ°Ý°è/·ù¸¶Æ¼½º Chapter 01. [Drug Class Review] ±Ù°ñ°Ý¿¡ ÁÖ·Î »ç¿ëµÇ´Â ¾à¹° Topic 1. ±ÙÀÌ¿ÏÁ¦ -------- 548
Chapter 02. Áõ»ó/Áúȯº° ¾àó¹æÀÇ Á¤¼® Topic 2. ·ù¸¶Æ¼½º°üÀý¿° -------- 556 Topic 3. °ñ°üÀý¿° -------- 583 Topic 4. Åëdz -------- 595 Topic 5. Àü½ÅÈ«¹Ý·çǪ½º -------- 615
PART 11. ÇǺΠChapter 01. [Drug Class Review] ÇǺο¡ ÁÖ·Î »ç¿ëµÇ´Â ¾à¹° Topic 1. ÇǺοܿëÁ¦: ±¹¼Ò ½ºÅ×·ÎÀ̵å Á¦Á¦(topical corticosteroid) -------- 624 Topic 2. ÇǺοܿëÁ¦: ±¹¼Ò ¸é¿ªÁ¶ÀýÁ¦(topical immunomodulator) -------- 631 Topic 3. ÇǺοܿëÁ¦: ±¹¼Ò Ç×»ýÁ¦(Ç×±ÕÁ¦, Ç×¹ÙÀÌ·¯½ºÁ¦, Ç×Áø±ÕÁ¦) -------- 636
Chapter 02. Áõ»ó/Áúȯº° ¾àó¹æÀÇ Á¤¼® Topic 4. ½ÀÁø -------- 642 4-1. ¾ÆÅäÇÇÇǺο° -------- 642 4-2. Áö·çÇǺο° -------- 650 Topic 5. °Ç¼± -------- 658 Topic 6. ¿©µå¸§ -------- 666 Topic 7. Å»¸ð -------- 679------- 745
Vol. 2
PART 6. ³»ºÐºñ
Chapter 01. [Drug Class Review] ³»ºÐºñ¿¡ ÁÖ·Î »ç¿ëµÇ´Â ¾à¹°
Topic 1. ºÎ½Å°ÑÁú È£¸£¸ó/±æÇ×Á¦ -------- 4
Topic 2. »ý½Ä»ù È£¸£¸ó/±æÇ×Á¦ -------- 6
2-1. »ý½Ä»ù È£¸£¸ó -------- 6
2-2. »ý½Ä»ù È£¸£¸ó ±æÇ×Á¦ -------- 18
Chapter 02. Áõ»ó/Áúȯº° ¾àó¹æÀÇ Á¤¼®
Topic 3. °©»ó»ù Áúȯ -------- 32
3-1. °©»ó»ù ±â´ÉÀúÇÏÁõ -------- 32
[Âü°í] °©»ó»ù ÁúȯÀ» ÀÌÇØÇϱâ À§ÇÑ ±âÃÊ -------- 32
3-2. °©»ó»ù ±â´ÉÇ×ÁøÁõ -------- 42
Topic 4. ´ç´¢º´ -------- 52
4-1. ´ç´¢º´: Ä¡·á ¹× ¾à¹°¿ä¹ý Overview -------- 52
4-2. ´ç´¢º´: ¾à¹°¿ä¹ý-°æ±¸Ç÷´ç°ÇÏÁ¦ -------- 78
[SUPPLEMENT] Incretin °ü·Ã ¾à¹° -------- 87
4-3. ´ç´¢º´: ¾à¹°¿ä¹ý-ÁÖ»çÁ¦ -------- 96
Topic 5. ÀÌ»óÁöÁúÇ÷Áõ -------- 103
[SPECIAL REVIEW] PCSK9 (Proprotein convertase subtilisin-kexin type 9) ¾ïÁ¦Á¦ -------- 120
Topic 6. ºñ¸¸ -------- 121
[SPECIAL REVIEW] GLP-1 agonist: Liraglutide (Saxenda) -------- 130
Topic 7. °ñ´Ù°øÁõ -------- 142
[SPECIAL REVIEW] °ñ´Ù°øÁõ: ¾à¹°¿ä¹ý: Denosumab (RANKL ´ÜÀÏŬ·ÐÇ×ü) -------- 161
Topic 8. Æó°æ(¿©¼º°»³â±â ÁõÈıº) -------- 178
Topic 9. ³²¼º°»³â±â ÁõÈıº -------- 185
PART 7. ¿ä·Î»ý½Ä±â
Chapter 01. [Drug Class Review] ¿ä·Î»ý½Ä±â¿¡ ÁÖ·Î »ç¿ëµÇ´Â ¾à¹°
Topic 1. ÇϺοä·ÎÁõ»ó/¹è´¢Àå¾Ö¿¡ »ç¿ëµÇ´Â ¾à¹° -------- 197
Chapter 02. Áõ»ó/Áúȯº° ¾àó¹æÀÇ Á¤¼®
Topic 2. ÇϺοä·ÎÁõ»ó/¹è´¢Àå¾Ö -------- 198
2-1. Àü¸³¼±ºñ´ëÁõ -------- 198
2-2. °ú¹Î¼º ¹æ±¤ -------- 215
[SPECIAL REVIEW] °ú¹Î¼º¹æ±¤: ¾à¹°¿ä¹ý: º£Å¸3 ¾Æµå·¹³¯¸° ¼ö¿ëü ÀÛ¿ëÁ¦: mirabegron -------- 220
2-3. ¿ä½Ç±Ý -------- 226
Topic 3. ³²¼º ¼º±â´ÉÀå¾Ö -------- 234
3-1. ¹ß±âºÎÀü -------- 234
3-2. Á¶·çÁõ -------- 246
PART 8. ½Å°æ/Á¤½Å
Chapter 01. [Drug Class Review] ½Å°æ/Á¤½Å°è¿¡ ÁÖ·Î »ç¿ëµÇ´Â ¾à¹°
Topic 1. GABA ¹× Glutamate¼º ½Å°æÀü´Þ °ü·Ã¾à¹° -------- 256
[Âü°í] GABA/Glutamate -------- 256
1-1. Benzodiazepine -------- 258
1-2. Barbiturate -------- 269
1-3. Ç׳úÀüÁõÁ¦ -------- 275
[SPECIAL REVIEW] Gabapentenoids: gabapentin, pregabalin -------- 292
Topic 2. µµÆĹΠ½Å°æÀü´Þ °ü·Ã¾à¹° -------- 297
2-1. Ç×Á¤½Åº´Á¦ -------- 297
Topic 3. Adrenergic, serotonergic ½Å°æÀü´Þ °ü·Ã¾à¹° -------- 315
3-1. Ç׿ì¿ïÁ¦ -------- 315
3-2. ±âºÐÁ¶ÀýÁ¦ -------- 334
Topic 4. ±âŸ -------- 338
4-1. Á¤½ÅÀÚ±ØÁ¦ -------- 338
Chapter 02. Áõ»ó/Áúȯº° ¾àó¹æÀÇ Á¤¼®
Topic 5. ÆíµÎÅë -------- 346
Topic 6. ¶³¸²/ÆÄŲ½¼º´ -------- 370
Topic 7. ¹ßÀÛ(seizure)/³úÀüÁõ(epilepsy) -------- 390
Topic 8. ¾îÁö·³Áõ -------- 398
Topic 9. Ä¡¸Å -------- 406
Topic 10. ºÒ¾ÈÀå¾Ö -------- 423
Topic 11. ¿ì¿ïÀå¾Ö -------- 435
Topic 12. ¼ö¸éÀå¾Ö -------- 448
Topic 13. ÁÖÀǷ°áÇÌ°úÀ×ÇൿÀå¾Ö(ADHD) -------- 470
Topic 14. Èí¿¬(±Ý¿¬¾à¹°) -------- 481
PART 9. ´« ¤ý ±Í ¤ý ÄÚ ¤ý µÎ°æºÎ
Chapter 01. [Drug Class Review] ´«, ±Í, ÄÚ, µÎ°æºÎ¿¡ ÁÖ·Î »ç¿ëµÇ´Â ¾à¹°
Topic 1. ¿Ü¿ëÁ¦(Á¡¾ÈÁ¦) -------- 500
[SUPPLEMENT] ¾È¾àÀÇ ¿Ã¹Ù¸¥ »ç¿ë¹æ¹ý -------- 503
Topic 2. ¿Ü¿ëÁ¦(Á¡ÀÌÁ¦) -------- 506
[SUPPLEMENT] Á¡ÀÌÁ¦ÀÇ ¿Ã¹Ù¸¥ »ç¿ë¹æ¹ý -------- 507
Chapter 02. Áõ»ó/Áúȯº° ¾àó¹æÀÇ Á¤¼®
Topic 3. ¿ÜÀ̵µ¿° -------- 510
Topic 4. ¾È±¸°ÇÁ¶Áõ -------- 515
Topic 5. °á¸·¿°: ¾Ë·¹¸£±â°á¸·¿°À» Áß½ÉÀ¸·Î -------- 528
Topic 6. ³ì³»Àå -------- 536
PART 10. ±Ù°ñ°Ý°è/·ù¸¶Æ¼½º
Chapter 01. [Drug Class Review] ±Ù°ñ°Ý¿¡ ÁÖ·Î »ç¿ëµÇ´Â ¾à¹°
Topic 1. ±ÙÀÌ¿ÏÁ¦ -------- 548
Chapter 02. Áõ»ó/Áúȯº° ¾àó¹æÀÇ Á¤¼®
Topic 2. ·ù¸¶Æ¼½º°üÀý¿° -------- 556
Topic 3. °ñ°üÀý¿° -------- 583
Topic 4. Åëdz -------- 595
Topic 5. Àü½ÅÈ«¹Ý·çǪ½º -------- 615
PART 11. ÇǺÎ
Chapter 01. [Drug Class Review] ÇǺο¡ ÁÖ·Î »ç¿ëµÇ´Â ¾à¹°
Topic 1. ÇǺοܿëÁ¦: ±¹¼Ò ½ºÅ×·ÎÀ̵å Á¦Á¦(topical corticosteroid) -------- 624
Topic 2. ÇǺοܿëÁ¦: ±¹¼Ò ¸é¿ªÁ¶ÀýÁ¦(topical immunomodulator) -------- 631
Topic 3. ÇǺοܿëÁ¦: ±¹¼Ò Ç×»ýÁ¦(Ç×±ÕÁ¦, Ç×¹ÙÀÌ·¯½ºÁ¦, Ç×Áø±ÕÁ¦) -------- 636
Chapter 02. Áõ»ó/Áúȯº° ¾àó¹æÀÇ Á¤¼®
Topic 4. ½ÀÁø -------- 642
4-1. ¾ÆÅäÇÇÇǺο° -------- 642
4-2. Áö·çÇǺο° -------- 650
Topic 5. °Ç¼± -------- 658
Topic 6. ¿©µå¸§ -------- 666
Topic 7. Å»¸ð -------- 679
-
-
ÀÌ Ã¥ÀÇ ÁýÇÊ µ¿±â´Â ÇѸ¶µð·Î »ó´ë¸¦ ¾Ë°í ³ª¸¦ ¾Ë¸é ¹é ¹ø ½Î¿öµµ À§Å·ÓÁö ¾Ê´Ù´Â "ÁöÇÇÁö±â ¹éÀüºÒÅÂ" Á¤½ÅÀÔ´Ï´Ù.
ÀÇ»ç ÀÔÀå¿¡¼ "ÁöÇÇ"´Â ´Ù½º·Á¾ß ÇÒ Áúº´ÀÇ Á¤Ã¼¸¦ Á¦´ë·Î ÆľÇÇØ¾ß ÇÑ´Ù´Â Àǹ̰ÚÁö¿ä. ¹Ý¸é "Áö±â"´Â ³» ¼Õ¿¡ Áã¾îÁø ¹«±â¸¦ Á¦´ë·Î ¾Ë°í ´É¼÷ÇÏ°Ô »ç¿ëÇØ¾ß ÇÑ´Ù´Â ¶æÀ¸·Î ´Ù°¡¿É´Ï´Ù. È°¿ë °¡´ÉÇÑ ¹«±â¶õ ¿Ü°ú°è Àǻ翡°Õ ¼ö¼úÀÏ Å×°í, ³»°ú°è Àǻ翡°Ô´Â ´Ü¿¬ÄÚ ¾à¹°ÀÌ°ÚÁÒ. ¾à¿¡ ´ëÇÑ Æ÷°ýÀû ÀÌÇØ ¾øÀÌ ¾àÀ» ó¹æÇÏ°í ½ÍÁö ¾Ê¾Ò½À´Ï´Ù. ÇÏÁö¸¸ ¹«¼öÈ÷ ¸¹Àº ¾àÀÌ Á¸ÀçÇϱ⿡ ÀÌµé ¾àÀÇ Á¤Ã¼¸¦ ÇϳªÇϳª ÆľÇÇÑ´Ù´Â °Ç ¹«Ã´À̳ª ¹ö°Å¿î °úÁ¤ÀÏ °Ì´Ï´Ù. ¾àÀº ´ë°³ ÀÛ¿ë±âÀüÀ̳ª »ç¿ë ¸ñÀû¿¡ µû¶ó ƯÁ¤ ¾à¹°±º("Drug class")À¸·Î ºÐ·ùµÇ±â ¶§¹®¿¡ "Drug class"º°·Î ¹¾î¼ Ư¡À» ÆľÇÇÑ´Ù¸é ¼Ò±âÀÇ ¸ñÀûÀº ´Þ¼ºÇÏ´Â ¼ÀÀÌ°ÚÁö¿ä. ÀÌ°Ô ¹Ù·Î º» Ã¥ÀÌ Ãß±¸ÇÏ´Â "Drug class review"ÀÔ´Ï´Ù. ÇÏÁö¸¸ º» Ã¥Àº ´Ü¼øÈ÷ ¾à¿¡ ´ëÇÑ Á¤º¸¸¸À» Á¦°øÇϱâ À§ÇÑ Ã¥Àº ¾Æ´Õ´Ï´Ù. ¾à¿¡ ´ëÇÑ Æ÷°ýÀû ÀÌÇØ¿¡¼ ÇÑ¹ß ´õ ³ª¾Æ°¡ °¡À̵å¶óÀÎÀ̳ª ±Ù°Å ±â¹ÝÀ¸·Î ¾àÀ» ó¹æÇÏ´Â ½ÇÀüÁöħÀ» Á¦½ÃÇÏ´Â °ÍÀÌ ÀÌ Ã¥ÀÇ ±Ã±ØÀûÀÎ ÁöÇâÁ¡ÀÔ´Ï´Ù. ÀÌ°ÍÀÌ ¹Ù·Î "Real world prescription"À̶ó´Â ºÎÁ¦¿¡ ´ã±ä ÀǹÌÀÔ´Ï´Ù. ÀÇ»ç·Î »ì¾Æ°¡´Â µ¿¾È ¶¼·Á¾ß ¶¿ ¼ö ¾ø´Â °Ô ¾àÀ̱⿡ ¾à¿¡ ´ëÇÑ °í¹ÎÀº Áö¼ÓµÉ ¼ö¹Û¿¡ ¾ø½À´Ï´Ù. ±×·¸Áö¸¸ ²÷ÀÓ¾øÀÌ ½Å¾àÀÌ ½ñ¾ÆÁ® ³ª¿À°í ±âÁ¸ ¾àÀÇ ¿ëµµµµ »õ·Ó°Ô Á¤ÀǵǴ µî ¾à¿¡ ´ëÇÑ ÃÖ½ÅÁ¤º¸¸¦ ¾÷µ¥ÀÌÆ®Çϱâ´Â ½±Áö ¾Ê½À´Ï´Ù. º» Ã¥ÀÌ ¾à¿¡ ´ëÇÑ À¯¿ëÇÑ Âü°í¼·Î ÀÚ¸®¸Å±èÇÏ¿© ¾àÀ» Á¦´ë·Î ¾Ë°í º¸´Ù ¹Ù¸¥ ó¹æÀ» ³»¸®´Â µ¥ ÀÏÁ¶ÇßÀ¸¸é ÇÏ´Â ¹Ù¶÷ÀÔ´Ï´Ù.
(/ '¼¹®' Áß¿¡¼)[¼¹®]
Ã¥À» º¸½Ã±â Àü¿¡
ÀÌ Ã¥ÀÇ ÁýÇÊ µ¿±â´Â ÇѸ¶µð·Î »ó´ë¸¦ ¾Ë°í ³ª¸¦ ¾Ë¸é ¹é ¹ø ½Î¿öµµ À§Å·ÓÁö ¾Ê´Ù´Â "ÁöÇÇÁö±â ¹éÀüºÒÅÂ" Á¤½ÅÀÔ´Ï´Ù.
ÀÇ»ç ÀÔÀå¿¡¼ "ÁöÇÇ"´Â ´Ù½º·Á¾ß ÇÒ Áúº´ÀÇ Á¤Ã¼¸¦ Á¦´ë·Î ÆľÇÇØ¾ß ÇÑ´Ù´Â Àǹ̰ÚÁö¿ä. ¹Ý¸é "Áö±â"´Â ³» ¼Õ¿¡ Áã¾îÁø ¹«±â¸¦ Á¦´ë·Î ¾Ë°í ´É¼÷ÇÏ°Ô »ç¿ëÇØ¾ß ÇÑ´Ù´Â ¶æÀ¸·Î ´Ù°¡¿É´Ï´Ù.
È°¿ë °¡´ÉÇÑ ¹«±â¶õ ¿Ü°ú°è Àǻ翡°Õ ¼ö¼úÀÏ Å×°í, ³»°ú°è Àǻ翡°Ô´Â ´Ü¿¬ÄÚ ¾à¹°ÀÌ°ÚÁÒ.
¾à¿¡ ´ëÇÑ Æ÷°ýÀû ÀÌÇØ ¾øÀÌ ¾àÀ» ó¹æÇÏ°í ½ÍÁö ¾Ê¾Ò½À´Ï´Ù. ÇÏÁö¸¸ ¹«¼öÈ÷ ¸¹Àº ¾àÀÌ Á¸ÀçÇϱ⿡ ÀÌµé ¾àÀÇ Á¤Ã¼¸¦ ÇϳªÇϳª ÆľÇÇÑ´Ù´Â °Ç ¹«Ã´À̳ª ¹ö°Å¿î °úÁ¤ÀÏ °Ì´Ï´Ù. ¾àÀº ´ë°³ ÀÛ¿ë±âÀüÀ̳ª »ç¿ë ¸ñÀû¿¡ µû¶ó ƯÁ¤ ¾à¹°±º("Drug class")À¸·Î ºÐ·ùµÇ±â ¶§¹®¿¡ "Drug class"º°·Î ¹¾î¼ Ư¡À» ÆľÇÇÑ´Ù¸é ¼Ò±âÀÇ ¸ñÀûÀº ´Þ¼ºÇÏ´Â ¼ÀÀÌ°ÚÁö¿ä. ÀÌ°Ô ¹Ù·Î º» Ã¥ÀÌ Ãß±¸ÇÏ´Â "Drug class review"ÀÔ´Ï´Ù.
ÇÏÁö¸¸ º» Ã¥Àº ´Ü¼øÈ÷ ¾à¿¡ ´ëÇÑ Á¤º¸¸¸À» Á¦°øÇϱâ À§ÇÑ Ã¥Àº ¾Æ´Õ´Ï´Ù.
¾à¿¡ ´ëÇÑ Æ÷°ýÀû ÀÌÇØ¿¡¼ ÇÑ¹ß ´õ ³ª¾Æ°¡ °¡À̵å¶óÀÎÀ̳ª ±Ù°Å ±â¹ÝÀ¸·Î ¾àÀ» ó¹æÇÏ´Â ½ÇÀüÁöħÀ» Á¦½ÃÇÏ´Â °ÍÀÌ ÀÌ Ã¥ÀÇ ±Ã±ØÀûÀÎ ÁöÇâÁ¡ÀÔ´Ï´Ù. ÀÌ°ÍÀÌ ¹Ù·Î "Real world prescription"À̶ó´Â ºÎÁ¦¿¡ ´ã±ä ÀǹÌÀÔ´Ï´Ù.
ÀÇ»ç·Î »ì¾Æ°¡´Â µ¿¾È ¶¼·Á¾ß ¶¿ ¼ö ¾ø´Â °Ô ¾àÀ̱⿡ ¾à¿¡ ´ëÇÑ °í¹ÎÀº Áö¼ÓµÉ ¼ö¹Û¿¡ ¾ø½À´Ï´Ù.
±×·¸Áö¸¸ ²÷ÀÓ¾øÀÌ ½Å¾àÀÌ ½ñ¾ÆÁ® ³ª¿À°í ±âÁ¸ ¾àÀÇ ¿ëµµµµ »õ·Ó°Ô Á¤ÀǵǴ µî ¾à¿¡ ´ëÇÑ ÃÖ½ÅÁ¤º¸¸¦ ¾÷µ¥ÀÌÆ®Çϱâ´Â ½±Áö ¾Ê½À´Ï´Ù.
º» Ã¥ÀÌ ¾à¿¡ ´ëÇÑ À¯¿ëÇÑ Âü°í¼·Î ÀÚ¸®¸Å±èÇÏ¿© ¾àÀ» Á¦´ë·Î ¾Ë°í º¸´Ù ¹Ù¸¥ ó¹æÀ» ³»¸®´Â µ¥ ÀÏÁ¶ÇßÀ¸¸é ÇÏ´Â ¹Ù¶÷ÀÔ´Ï´Ù.
2020³â 5¿ù 31ÀÏ
ÀúÀÚ ÀÌ»óºÀ
-
-
|
ÀÌ»óºÀ [Àú]
|
|
-
-
-
Àüü 0°³ÀÇ ±¸¸ÅÈıⰡ ÀÖ½À´Ï´Ù.
|
ÀÎÅÍÆÄÅ©µµ¼´Â °í°´´ÔÀÇ ´Ü¼ø º¯½É¿¡ ÀÇÇÑ ±³È¯°ú ¹ÝÇ°¿¡ µå´Â ºñ¿ëÀº °í°´´ÔÀÌ ÁöºÒÄÉ µË´Ï´Ù.
´Ü, »óÇ°À̳ª ¼ºñ½º ÀÚüÀÇ ÇÏÀÚ·Î ÀÎÇÑ ±³È¯ ¹× ¹ÝÇ°Àº ¹«·á·Î ¹ÝÇ° µË´Ï´Ù. |
|
±³È¯ ¹× ¹ÝÇ°ÀÌ °¡´ÉÇÑ °æ¿ì |
»óÇ°À» °ø±Þ ¹ÞÀº ³¯·ÎºÎÅÍ 7ÀÏÀ̳» °¡´É
°ø±Þ¹ÞÀ¸½Å »óÇ°ÀÇ ³»¿ëÀÌ Ç¥½Ã, ±¤°í ³»¿ë°ú ´Ù¸£°Å³ª ´Ù¸£°Ô ÀÌÇàµÈ °æ¿ì¿¡´Â °ø±Þ¹ÞÀº ³¯·ÎºÎÅÍ 3°³¿ù À̳», ȤÀº ±×»ç½ÇÀ» ¾Ë°Ô µÈ ³¯ ¶Ç´Â ¾Ë ¼ö ÀÖ¾ú´ø ³¯·ÎºÎÅÍ 30ÀÏ À̳»
»óÇ°¿¡ ¾Æ¹«·± ÇÏÀÚ°¡ ¾ø´Â °æ¿ì ¼ÒºñÀÚÀÇ °í°´º¯½É¿¡ ÀÇÇÑ ±³È¯Àº »óÇ°ÀÇ Æ÷Àå»óÅ µîÀÌ ÀüÇô ¼Õ»óµÇÁö ¾ÊÀº °æ¿ì¿¡ ÇÑÇÏ¿© °¡´É |
|
±³È¯ ¹× ¹ÝÇ°ÀÌ ºÒ°¡´ÉÇÑ °æ¿ì |
±¸¸ÅÈ®Á¤ ÀÌÈÄ(¿ÀǸ¶ÄÏ»óÇ°¿¡ ÇÑÇÔ)
°í°´´ÔÀÇ Ã¥ÀÓ ÀÖ´Â »çÀ¯·Î »óÇ° µîÀÌ ¸ê½Ç ¶Ç´Â ÈÑ¼ÕµÈ °æ¿ì
(´Ü, »óÇ°ÀÇ ³»¿ëÀ» È®ÀÎÇϱâ À§ÇÏ¿© Æ÷Àå µîÀ» ÈѼÕÇÑ °æ¿ì´Â Á¦¿Ü)
½Ã°£ÀÌ Áö³²¿¡ µû¶ó ÀçÆǸŰ¡ °ï¶õÇÒ Á¤µµ·Î ¹°Ç°ÀÇ °¡Ä¡°¡ ¶³¾îÁø °æ¿ì
Æ÷Àå °³ºÀµÇ¾î »óÇ° °¡Ä¡°¡ ÈÑ¼ÕµÈ °æ¿ì |
|
´Ù¹è¼ÛÁöÀÇ °æ¿ì ¹ÝÇ° ȯºÒ |
´Ù¹è¼ÛÁöÀÇ °æ¿ì ´Ù¸¥ Áö¿ªÀÇ ¹ÝÇ°À» µ¿½Ã¿¡ ÁøÇàÇÒ ¼ö ¾ø½À´Ï´Ù.
1°³ Áö¿ªÀÇ ¹ÝÇ°ÀÌ ¿Ï·áµÈ ÈÄ ´Ù¸¥ Áö¿ª ¹ÝÇ°À» ÁøÇàÇÒ ¼ö ÀÖÀ¸¹Ç·Î, ÀÌÁ¡ ¾çÇØÇØ Áֽñ⠹ٶø´Ï´Ù. |
|
Áß°í»óÇ°ÀÇ ±³È¯ |
Áß°í»óÇ°Àº Á¦ÇÑµÈ Àç°í ³»¿¡¼ ÆǸŰ¡ ÀÌ·ç¾îÁö¹Ç·Î, ±³È¯Àº ºÒ°¡´ÉÇÕ´Ï´Ù. |
|
¿ÀǸ¶ÄÏ »óÇ°ÀÇ È¯ºÒ |
¿ÀǸ¶ÄÏ»óÇ°¿¡ ´ëÇÑ Ã¥ÀÓÀº ¿øÄ¢ÀûÀ¸·Î ¾÷ü¿¡°Ô ÀÖÀ¸¹Ç·Î, ±³È¯/¹ÝÇ° Á¢¼ö½Ã ¹Ýµå½Ã ÆǸÅÀÚ¿Í ÇùÀÇ ÈÄ ¹ÝÇ° Á¢¼ö¸¦ ÇϼžßÇϸç, ¹ÝÇ°Á¢¼ö ¾øÀÌ ¹Ý¼ÛÇϰųª, ¿ìÆíÀ¸·Î º¸³¾ °æ¿ì »óÇ° È®ÀÎÀÌ ¾î·Á¿ö ȯºÒÀÌ ºÒ°¡´ÉÇÒ ¼ö ÀÖÀ¸´Ï À¯ÀÇÇϽñ⠹ٶø´Ï´Ù. |
|
|
|
¹è¼Û¿¹Á¤ÀÏ ¾È³» |
ÀÎÅÍÆÄÅ© µµ¼´Â ¸ðµç »óÇ°¿¡ ´ëÇØ ¹è¼Û¿Ï·á¿¹Á¤ÀÏÀ» À¥»çÀÌÆ®¿¡ Ç¥½ÃÇÏ°í ÀÖ½À´Ï´Ù.
|
<ÀÎÅÍÆÄÅ© Á÷¹è¼Û »óÇ°> |
»óÇ°Àº ¿ù~Åä¿äÀÏ ¿ÀÀü 10½Ã ÀÌÀü ÁÖ¹®ºÐ¿¡ ´ëÇÏ¿© ´çÀÏ Ãâ°í/´çÀÏ ¹è¼Û¿Ï·á¸¦ º¸ÀåÇÏ´Â »óÇ°ÀÔ´Ï´Ù. |
»óÇ°Àº ¼¿ïÁö¿ª/ÆòÀÏ ÁÖ¹®ºÐÀº ´çÀÏ Ãâ°í/ÀÍÀÏ ¹è¼Û¿Ï·á¸¦ º¸ÀåÇϸç,
¼¿ï¿ÜÁö¿ª/ÆòÀÏ ÁÖ¹®ºÐÀÇ °æ¿ì´Â ¿ÀÈÄ 6½Ã±îÁö ÁÖ¹®ºÐ¿¡ ´ëÇÏ¿© ÀÍÀÏ ¹è¼Û¿Ï·á¸¦ º¸ÀåÇÏ´Â »óÇ°ÀÔ´Ï´Ù.
(´Ü, ¿ù¿äÀÏÀº 12½Ã±îÁö ÁÖ¹®¿¡ ÇÑÇÔ)
|
»óÇ°Àº, ÀÔ°í¿¹Á¤ÀÏ(Á¦Ç°Ãâ½ÃÀÏ)+Åùè»ç¹è¼ÛÀÏ(1ÀÏ)¿¡ ¹è¼Û¿Ï·á¸¦ º¸ÀåÇÕ´Ï´Ù. |
~
»óÇ°Àº À¯ÅëƯ¼º»ó ÀÎÅÍÆÄÅ©¿¡¼ Àç°í¸¦ º¸À¯ÇÏÁö ¾ÊÀº »óÇ°À¸·Î ÁÖ¹®ÀÏ+±âÁØÃâ°íÀÏ+Åùè»ç¹è¼ÛÀÏ(1ÀÏ)¿¡ ¹è¼Û¿Ï·á¸¦ º¸ÀåÇÕ´Ï´Ù.(Åä/°øÈÞÀÏÀº ¹è¼Û±â°£¿¡ Æ÷ÇÔµÇÁö ¾Ê½À´Ï´Ù.)
¡Ø±âÁØÃâ°íÀÏ:ÀÎÅÍÆÄÅ©°¡ »óÇ°À» ¼ö±ÞÇÏ¿© ¹°·ùâ°í¿¡¼ Æ÷Àå/Ãâ°íÇϱâ±îÁö ¼Ò¿äµÇ´Â ½Ã°£
|
|
<¾÷ü Á÷Á¢¹è¼Û/¿ÀǸ¶ÄÏ »óÇ°> |
~
»óÇ°Àº ¾÷ü°¡ ÁÖ¹®À» È®ÀÎÇÏ°í, Ãâ°íÇϱâ±îÁö °É¸®´Â ½Ã°£ÀÔ´Ï´Ù. ÁÖ¹®ÀÏ+±âÁØÃâ°íÀÏ+Åùè»ç¹è¼ÛÀÏ(2ÀÏ)¿¡ ¹è¼Û¿Ï·á¸¦ º¸ÀåÇÕ´Ï´Ù.(Åä/°øÈÞÀÏÀº ¹è¼Û±â°£¿¡ Æ÷ÇÔµÇÁö ¾Ê½À´Ï´Ù.)
¡Ø5ÀÏÀ̳» Ãâ°í°¡ ½ÃÀÛµÇÁö ¾ÊÀ»½Ã, ¿ÀǸ¶ÄÏ »óÇ°Àº ÀÚµ¿À¸·Î ÁÖ¹®ÀÌ Ãë¼ÒµÇ¸ç, °í°´´Ô²² Ç°Àýº¸»ó±ÝÀ» Áö±ÞÇØ µå¸³´Ï´Ù.
|
|
|
¹è¼Ûºñ ¾È³» |
µµ¼(Áß°íµµ¼ Æ÷ÇÔ)¸¸ ±¸¸ÅÇϽøé : ¹è¼Ûºñ 2,000¿ø (1¸¸¿øÀÌ»ó ±¸¸Å ½Ã ¹«·á¹è¼Û) À½¹Ý/DVD¸¸ ±¸¸ÅÇϽøé : ¹è¼Ûºñ 1,500¿ø (2¸¸¿øÀÌ»ó ±¸¸Å ½Ã ¹«·á¹è¼Û)
ÀâÁö/¸¸È/±âÇÁÆ®¸¸ ±¸¸ÅÇϽøé : ¹è¼Ûºñ 2,000¿ø (2¸¸¿øÀÌ»ó ±¸¸Å ½Ã ¹«·á¹è¼Û)
µµ¼¿Í À½¹Ý/DVD¸¦ ÇÔ²² ±¸¸ÅÇϽøé : ¹è¼Ûºñ 1,500¿ø 1¸¸¿øÀÌ»ó ±¸¸Å ½Ã ¹«·á¹è¼Û)
µµ¼¿Í ÀâÁö/¸¸È/±âÇÁÆ®/Áß°íÁ÷¹è¼Û»óÇ°À» ÇÔ²² ±¸¸ÅÇϽøé : 2,000¿ø (1¸¸¿øÀÌ»ó ±¸¸Å ½Ã ¹«·á¹è¼Û)
¾÷üÁ÷Á¢¹è¼Û»óÇ°À» ±¸¸Å½Ã : ¾÷üº°·Î »óÀÌÇÑ ¹è¼Ûºñ Àû¿ë
* ¼¼Æ®»óÇ°ÀÇ °æ¿ì ºÎºÐÃë¼Ò ½Ã Ãß°¡ ¹è¼Ûºñ°¡ ºÎ°úµÉ ¼ö ÀÖ½À´Ï´Ù.
* ºÏÄ«Æ®¿¡¼ ¹è¼Ûºñ¾ø¾Ö±â ¹öÆ°À» Ŭ¸¯Çϼż, µ¿ÀϾ÷ü»óÇ°À» Á¶±Ý ´õ ±¸¸ÅÇϽøé, ¹è¼Ûºñ¸¦ Àý¾àÇÏ½Ç ¼ö ÀÖ½À´Ï´Ù.
|
|
Çؿܹè¼Û ¾È³» |
ÀÎÅÍÆÄÅ©µµ¼¿¡¼´Â ±¹³»¿¡¼ ÁÖ¹®ÇϽðųª ÇØ¿Ü¿¡¼ ÁÖ¹®ÇÏ¿© ÇØ¿Ü·Î ¹è¼ÛÀ» ¿øÇÏ½Ç °æ¿ì DHL°ú Ư¾àÀ¸·Î Ã¥Á¤µÈ ¿ä±ÝÇ¥¿¡
ÀÇÇØ °³ÀÎÀÌ ÀÌ¿ëÇÏ´Â °æ¿ìº¸´Ù ¹è¼Û¿ä±ÝÀ» Å©°Ô ³·Ã߸ç DHL(www.dhl.co.kr)·Î Çؿܹè¼Û ¼ºñ½º¸¦ Á¦°øÇÕ´Ï´Ù.
Çؿܹè¼ÛÀº µµ¼/CD/DVD »óÇ°¿¡ ÇÑÇØ ¼ºñ½ºÇÏ°í ÀÖÀ¸¸ç, ´Ù¸¥ »óÇ°À» ºÏÄ«Æ®¿¡ ÇÔ²² ´ãÀ¸½Ç °æ¿ì Çؿܹè¼ÛÀÌ ºÒ°¡ÇÕ´Ï´Ù.
ÇØ¿ÜÁÖ¹®¹è¼Û ¼ºñ½º´Â ÀÎÅÍÆÄÅ© µµ¼ ȸ¿ø °¡ÀÔÀ» Çϼž߸¸ ½Åû °¡´ÉÇÕ´Ï´Ù. |
|
¾Ë¾ÆµÎ¼¼¿ä!!! |
µµ¸Å»ó ¹× Á¦ÀÛ»ç »çÁ¤¿¡ µû¶ó Ç°Àý/ÀýÆÇ µîÀÇ »çÀ¯·Î Ãë¼ÒµÉ ¼ö ÀÖ½À´Ï´Ù.
¿ÀǸ¶ÄϾ÷üÀÇ ¹è¼ÛÁö¿¬½Ã ÁÖ¹®ÀÌ ÀÚµ¿À¸·Î Ãë¼ÒµÉ ¼ö ÀÖ½À´Ï´Ù.
Ãâ°í°¡´É ½Ã°£ÀÌ ¼·Î ´Ù¸¥ »óÇ°À» ÇÔ²² ÁÖ¹®ÇÒ °æ¿ì Ãâ°í°¡´É ½Ã°£ÀÌ °¡Àå ±ä ±âÁØÀ¸·Î ¹è¼ÛµË´Ï´Ù.
À¯ÅëÀÇ Æ¯¼º»ó Ãâ°í±â°£Àº ¿¹Á¤º¸´Ù ¾Õ´ç°ÜÁö°Å³ª ´ÊÃçÁú ¼ö ÀÖ½À´Ï´Ù.
Åùè»ç ¹è¼ÛÀÏÀÎ ¼¿ï ¹× ¼öµµ±ÇÀº 1~2ÀÏ, Áö¹æÀº 2~3ÀÏ, µµ¼, »ê°£, ±ººÎ´ë´Â 3ÀÏ ÀÌ»óÀÇ ½Ã°£ÀÌ ¼Ò¿äµË´Ï´Ù. |
|
|
|
|